TipRanks
Advertisement
Advertisement

CRVS Stock Latest News

Corvus announces initiation of Phase 1b clinical trial of soquelitinib
The FlyCorvus announces initiation of Phase 1b clinical trial of soquelitinib
7m ago
CRVS
Corvus Pharmaceuticals’ Earnings Call Signals High-Stakes Expansion
PremiumCompany Announcements
Corvus Pharmaceuticals’ Earnings Call Signals High-Stakes Expansion
1M ago
CRVS
Analyst Reiterates Buy on Corvus Pharmaceuticals, Maintains $27 Price Target Amid Advancing Clinical Pipeline
PremiumRatings
Analyst Reiterates Buy on Corvus Pharmaceuticals, Maintains $27 Price Target Amid Advancing Clinical Pipeline
2M ago
CRVS
Corvus Pharmaceuticals reports Q2 EPS (19c), consensus (17c)
PremiumThe Fly
Corvus Pharmaceuticals reports Q2 EPS (19c), consensus (17c)
2M ago
CRVS
Corvus Pharmaceuticals Announces Board Leadership Transition
PremiumCompany Announcements
Corvus Pharmaceuticals Announces Board Leadership Transition
2M ago
8K
CRVS
Corvus Stockholders Approve Directors and Governance Proposals
PremiumCompany AnnouncementsCorvus Stockholders Approve Directors and Governance Proposals
4M ago
8K
CRVS
Buy Rating Reaffirmed on Corvus as Soquelitinib Data Strengthen Thesis; $27 Price Target Maintained
Premium
Ratings
Buy Rating Reaffirmed on Corvus as Soquelitinib Data Strengthen Thesis; $27 Price Target Maintained
5M ago
CRVS
Corvus Pharmaceuticals Unveils Positive Phase 1 Dermatitis Results
Premium
Company Announcements
Corvus Pharmaceuticals Unveils Positive Phase 1 Dermatitis Results
5M ago
8K
CRVS
Corvus Pharmaceuticals reports Q1 EPS (15c), consensus (15c)
PremiumThe Fly
Corvus Pharmaceuticals reports Q1 EPS (15c), consensus (15c)
5M ago
CRVS
Corvus Pharmaceuticals Announces Board Changes and New Director
PremiumCompany Announcements
Corvus Pharmaceuticals Announces Board Changes and New Director
5M ago
8K
CRVS
Apple upgraded, Qualcomm downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Apple upgraded, Qualcomm downgraded: Wall Street’s top analyst calls
6M ago
SR
CLX
Corvus Pharmaceuticals initiated with a Buy at Goldman Sachs
PremiumThe Fly
Corvus Pharmaceuticals initiated with a Buy at Goldman Sachs
6M ago
CRVS
Corvus Pharmaceuticals Bets Big on Soquelitinib Pipeline
PremiumCompany AnnouncementsCorvus Pharmaceuticals Bets Big on Soquelitinib Pipeline
7M ago
CRVS
Corvus Pharmaceuticals Expands Equity Sales Capacity to $200 Million
Premium
Company Announcements
Corvus Pharmaceuticals Expands Equity Sales Capacity to $200 Million
7M ago
8K
CRVS
Corvus Pharmaceuticals price target raised to $33 from $32 at Oppenheimer
Premium
The Fly
Corvus Pharmaceuticals price target raised to $33 from $32 at Oppenheimer
7M ago
CRVS
Corvus Pharmaceuticals files automatic mixed securities shelf
PremiumThe Fly
Corvus Pharmaceuticals files automatic mixed securities shelf
7M ago
CRVS
Corvus Pharmaceuticals: Strengthened Cash Runway and Expanding Soquelitinib Pipeline Underpin Buy Rating and Attractive Risk‑Reward Profile
PremiumRatings
Corvus Pharmaceuticals: Strengthened Cash Runway and Expanding Soquelitinib Pipeline Underpin Buy Rating and Attractive Risk‑Reward Profile
7M ago
CRVS
Corvus Pharmaceuticals reports Q4 EPS (15c), consensus (13c)
PremiumThe Fly
Corvus Pharmaceuticals reports Q4 EPS (15c), consensus (13c)
7M ago
CRVS
Corvus Pharmaceuticals options imply 7.9% move in share price post-earnings
PremiumThe Fly
Corvus Pharmaceuticals options imply 7.9% move in share price post-earnings
7M ago
CRVS
Corvus’ Soquelitinib Trial Completion Adds a New Catalyst in the Atopic Dermatitis Market
PremiumCompany AnnouncementsCorvus’ Soquelitinib Trial Completion Adds a New Catalyst in the Atopic Dermatitis Market
7M ago
CRVS
Corvus Advances Soquelitinib Into Phase 2 Eczema Trial: What Investors Should Watch
Premium
Company Announcements
Corvus Advances Soquelitinib Into Phase 2 Eczema Trial: What Investors Should Watch
7M ago
CRVS
Corvus Pharmaceuticals options imply 5.5% move in share price post-earnings
Premium
The Fly
Corvus Pharmaceuticals options imply 5.5% move in share price post-earnings
7M ago
CRVS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >